HRT FINANCIAL LP sold $1K of PFSA
HRT FINANCIAL LP sold 1,307 shares of Profusa, Inc. (PFSA) at an average of $0.94 ($0.94–$0.95) across 2 trades over 2026-08-05 to 2026-08-07.
How this was made
The 30-second read
Why it matters
The newest disclosed fact is the specific open-market sale size, price range, and post-transaction holdings. However, there is no accompanying fundamental update (earnings, guidance, trial results, or corporate action) in the text provided.
Market read
Traders may note insider selling as a mild sentiment input, but the disclosed transaction value ($1,234.89) is unlikely to be a standalone driver.
What to watch
The article does not state whether the holder’s remaining stake is changing meaningfully over time, nor does it provide context on prior sales or total position size changes beyond the post-transaction share count.
Background
The filing is an SEC Form 4 insider transaction report for Profusa, Inc. (PFSA), reported by HRT Financial LP as a 10% owner.
Ticker impact
HRT Financial LP, a 10% owner of Profusa, sold 1,307 PFSA shares in open-market transactions at about $0.9448 weighted average.
Likely minimal near-term impact; any effect would be sentiment-driven rather than fundamental.
Form 4 shows an open-market sale by a large holder, but the article provides no new company-specific catalyst, guidance, or regulatory/legal development.
Market effects
No sector read-through beyond routine insider activity in a microcap/early-stage biotech context.
None indicated.
None indicated.
Counterpoint
The sale could be liquidity management or diversification rather than a bearish view, especially since it is not tied to a 10b5-1 plan in the filing.
Key entities
- issuerProfusa, Inc.
Public company whose shares (PFSA) were sold by a 10% owner via open-market transactions.
- insiderHRT Financial LP
10% owner that sold 1,307 shares of PFSA at an average price of about $0.9448.